Aripiprazole 400mg powder and solvent for prolonged-release suspension for injection pre-filled syringes
NHS hospitals in England used £15,907,871 of indicative cost of Aripiprazole 400mg powder and solvent for prolonged-release suspension for injection pre-filled syringes in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 28.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Aripiprazole 400mg powder and solvent for prolonged-release suspension for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Aripiprazole 400mg powder and solvent for prolonged-release suspension for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Cheshire & Wirral P/S Nhs Foundation Tr | £2,096,099 |
| Ctrl & N W London Nhs Foundation Trust | £1,153,406 |
| South London & Maudsley Nhs Found Trust | £823,011 |
| Essex Partnership University Nhs Ft | £741,680 |
| Midlands P/Ship Nhs Foundation Trust | £682,610 |
| Norfolk And Suffolk Nhs Foundation Trust | £632,577 |
| Northumberland Tyne And Wear Nhs Trust | £632,356 |
| Nottinghamshire Healthcare Nhs F Trust | £617,148 |
| Greater Manchester Mental Health Nhs Ft | £590,478 |
| Oxford Health Nhs Foundation Trust | £555,654 |
The primary-care picture
Aripiprazole is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Aripiprazole medicine page.